Publications by authors named "Ryan Kates"
J Pharm Technol
February 2022
Article Synopsis
- This study seeks to identify risk factors for nephrotoxicity associated with intravenous vancomycin in outpatient settings, as previous research has primarily focused on hospitalized patients.
- A case-control study found that 28.5% of patients receiving outpatient intravenous vancomycin developed acute kidney injury (AKI), with increased risk linked to longer therapy duration and higher vancomycin levels.
- Co-administration of fluoroquinolones or other nephrotoxic drugs significantly increased the chances of developing AKI, highlighting the need for further research to improve patient safety during outpatient antibiotic therapy.
